Research Advisory Board

The purpose of the Reverse Rett Research Advisory Board is to ensure that the research we fund at Reverse Rett meets the highest scientific and ethical standards. After a proposal has been through external peer review, the Research Advisory Board reviews the proposal and external peer reviews, as well as any subsequent exchange between applicants and external peer reviewers

After individual and group review, the Committee then provides cohesive feedback to the Board of Trustees of Reverse Rett. Their main role is to ensure that any work they recommend for funding meets AMRC research standards and aligns with the Reverse Rett Research Strategy.

The Reverse Rett Research Advisory Board comprises of professionals, including scientists, researchers and independent industry experts as well as patient voice representatives.

Reverse Rett Research Advisory Board

Dr. David Greatrex – Chair

Mrs Louise Wainwright Animal Welfare Officer

Deputy Bioscience Support Facility Manager

Nottingham Trent University

Independent Drug Development and Regulatory Affairs Consultant

M Regulatory Affairs Ltd

Dr. Mark E. S. Bailey

Senior Lecturer in Molecular Genetics,

School of Life Sciences, CMVLS, University of Glasgow

Dr. Ram Kumar, MA MB BChir MRCP (UK)

Consultant Paediatric Neurologist

Alder Hey Children’s Hospital

Dr. Gunter Loffler

John H. Sharpe, Chairman Reverse Rett Non-voting member

Dr. Jatinder Singh, Independent Scientific Advisor

Joanna Tomlin, Patient Voice